Announced Fri, 26 Jun · 11:30 IST
Gufic Biosciences closes trading window ahead of Q1 FY27 results
Compliance View source PDF
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+13.1%1-day move
₹358.65
prior close
₹361.65
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.5+0.4+2.6+13.1+10.1+7.2+7.9+4.8+7.0+9.4———
Up moveDown movePending
AI summary
Gufic Biosciences has closed its trading window from July 1, 2026, until 48 hours after the declaration of its unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026. The restriction applies to all Designated Persons and their immediate relatives under SEBI insider trading rules. The board meeting date to approve the Q1 FY27 results will be announced later. This is a routine compliance measure taken before quarterly earnings.
Likely market impact
Routine compliance. Insiders barred from trading until 48 hours after Q1 FY27 results. No direct stock price impact expected.